Skip to main content

Activated Carbon Particles Adsorbing Mitomycin C Used Against Peritoneal Carcinomatosis in Gastric Cancer

  • Chapter

Abstract

Peritoneal carcinomatosis is the most common mode of post-operative recurrence in gastric cancer patients [1], Prophylactic intraperitoneal administration of anticancer drugs in aqueous solution is not always efficacious. The small water-soluble molecules in commonly used anticancer drugs are absorbed rapidly from the peritoneal cavity into the circulation [2] and cannot maintain the concentration at an effective level for a long time. In contrast, corpuscular particles are gradually absorbed and are retained in the cavity [3]. We have developed a new dosage formulation to administer an anticancer drug in which mitomycin C is adsorbed onto activated carbon particles (MMC-CH). We present here basic experiments and a clinical study on the prophylactic effects of MMC-CH against peritoneal recurrence of gastric cancer.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dupont JB Jr, Lee JR, Burton GR, Cohn I Jr (1987) Adenocarcinoma of the stomach: review of 1497 cases, Cancer 41:941–947

    Article  Google Scholar 

  2. Rusznyak I, Foldi M, Szabo G (1967) Absorption of corpuscular particles from serous cavities. In: Youlten L (ed) Lymphatics and lymph circulation, 2nd edn. Pergamon, Oxford, pp 478–487

    Google Scholar 

  3. Rusznyak I, Foldi M, Szabo G (1967) Absorption of water and crystalloid molecules from serous cavities. In: Youlten L (ed) Lymphatics and lymph circulation, 2nd edn. Pergamon, Oxford, pp 495–497

    Google Scholar 

  4. Hagiwara A (1983) Mitomycin C adsorbed to activated carbon particles as a new drug dosage form for cancer chemotherapy (in Japanese). Akita J Med 10:187–229

    Google Scholar 

  5. Hagiwara A, Takahashi T, Lee R, Ueda T, Takeda M, Itoh T (1986) Selective delivery of high levels of mitomycin C to peritoneal carcinomatosis using a new dosage form. Anticancer Res 6:1161–1164

    PubMed  CAS  Google Scholar 

  6. Hagiwara A, Takahashi T, Lee R, Ueda T, Takeda M, Itoh T (1987) Chemotherapy for carcinomatous peritonitis with MMC-CH, mitomycin C adsorbed on activated carbon particles-clinical trials. Cancer 59:245–251

    Article  PubMed  CAS  Google Scholar 

  7. Hagiwara A, Takahashi T, Sawai K, Taniguchi H, Shimotsuma M, Okano S, Sakakura C, Tsujimoto H, Osaki K, Sasaki S, Shirasu M (1993) Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice. Cancer Res 53:687–692

    PubMed  CAS  Google Scholar 

  8. Hagiwara A, Takahashi T, Ueda T, Lee R, Takeda M, Itoh T (1987) Toxicity and pathological effects of a new dosage form of mitomycin C for carcinomatous peritonitis. Anticancer Res 7:105–108

    PubMed  CAS  Google Scholar 

  9. Hagiwara A, Takahahi T, Ueda T, Lee R, Takeda M, Itoh T (1987) Enhanced chemotherapeutic efficacy on carcinomatous peritonitis using a new dosage form in animal experiments. Anticancer Res 7:167–170

    PubMed  CAS  Google Scholar 

  10. Hagiwara A, Takahashi T, Ueda T, Lee R, Takeda M, Itoh T (1988) Intraoperative chemotherapy with carbon particles adsorbing mitomycin C for gastric cancer with peritoneal dissemination in rabbits. Surgery 104:871–881.

    Google Scholar 

  11. Iwamoto A, Sakita M, Inagake M, Hata M, Takahashi T, Hagiwara A (1987) Immunological study of the effects of mitomycin C adsorbed on activated carbon particles against carcinomatous peritonitis (in Japanese). Jpn J Gastroenterol Surg 20:371

    Google Scholar 

  12. Hagiwara A, Takahashi T, Kojima O, Sawai K, Yamaguchi T, Yamane T, Taniguchi H, Kitamura K, Noguchi A, Seiki K, Sakakura C (1992) Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet 339:629–631

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Japan

About this chapter

Cite this chapter

Hagiwara, A., Takahashi, T., Yamagishi, H. (1999). Activated Carbon Particles Adsorbing Mitomycin C Used Against Peritoneal Carcinomatosis in Gastric Cancer. In: Nakajima, T., Yamaguchi, T. (eds) Multimodality Therapy for Gastric Cancer. Springer, Tokyo. https://doi.org/10.1007/978-4-431-67927-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-67927-1_6

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68009-3

  • Online ISBN: 978-4-431-67927-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics